AVITHRAPID

Avithrapid email format

Verified email-pattern data for Avithrapid is currently limited. You can still use the company insights and contact sections below.
The European Consortium ""Antiviral Therapeutics for Rapid Response Against Pandemic Infectious Diseases"" (AVITHRAPID). The aim of the project is to establish a pipeline of small molecule-based antiviral agents that can be widely used and rapidly developed into therapies against emerging infectious diseases. As part of the project, the consortium intends to test a small molecule against Zika virus in a clinical trial. The European consortium "Antiviral Therapeutics for Rapid Response Against Pandemic Infectious Diseases" AVITHRAPID is part of the EU Horizon research programme call "Pandemic preparedness and response: Broad spectrum anti-viral therapeutics for infectious diseases with epidemic potential". The AVITHRAPID research consortium comprises 18 research institutions and companies from 8 countries, coordinated by the German Fraunhofer-Gesellschaft. AVITHRAPID started in January 2024 with a duration of 54 months .The Swiss Partners in the AVITHRAPID consortium are funded by the Swiss State Secretariat for Education, Research and Innovation SERI.
Looking for a particular AVITHRAPID employee's phone or email?

Avithrapid Questions

Explore related pages

Related company profiles:

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant